Navigation Links
Sciemetric makes the grade with major medical device manufacturer
Date:2/25/2009

the high standards demanded by a major player in this market, but also of helping them to further improve the quality, safety and efficiency of their manufacturing operations."

For almost 20 years, Sciemetric has been helping the largest manufacturing companies in the automotive, industrial component and medical sectors detect and analyze the root causes of defects in real time using a unique combination of superior on-the-floor defect-detection testing and sophisticated off-line analysis and reporting. Sciemetric's technology dramatically reduces defects and incidents of product recall that are both costly and damaging to a manufacturer's brand and reputation.

Today's announcement marks a significant milestone for Sciemetric in terms of its presence in this market and its goal to further diversify its business beyond the automotive sector.

"This is an exciting and new area of growth for us," said Sheaff. "We believe this relationship provides Sciemetric with the same strong foundation from which to grow in the medical device market that Ford Motor Co. provided us in the automotive market in the 1990s. While the application is different, the technology behind it is the same."

About Sciemetric Instruments

Founded in 1981, Sciemetric Instruments provides its manufacturing intelligence software and test platforms to companies around the world to detect and analyze manufacturing defects as they occur, improve quality, increase productivity and decrease costs across the entire production lifecycle. Headquartered in Ottawa, Canada, the company has its North American sales office in the U.S. and European offices in the UK.

For more information on Sciemetric, its technology and its record of accomplishments with major manufacturers, please visit www.sciemetric.com.


'/>"/>
SOURCE Sciemetric Instruments
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New Smart Technology Makes Patient Data Collection Easier, More Efficient
2. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
3. Independence Blue Cross Makes Music for Members Ears
4. A Place for Mom COO Makes Seattles 40 Under 40 List
5. Sesame Street Exhibition Makes Texas Premier at The Health Museum
6. Study makes progress in zoning in on biomarkers for better colon cancer treatment
7. New Online Tool Makes Enrollment in Blue Cross of California Easier
8. 1-800-PACK-RAT Makes a Splash During Annual Walk for Hope
9. Eye on Safety Makes Halloween Less Scary
10. An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal
11. Michigan State Medical Society Foundation Makes A Difference by Assisting Those in Crisis Shelters

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... ,, NEWORLEANS,Nov.23/PRNewswire/--Thanksgiv...#174;.Stronginitstradition,theClassicrepresentsthe...thanagameforthecityofNewOrleansandthoseinattendanc...GCWasche,thisisachanceforsomedowntimebeforetheywor..., Aftertwoyearsofconstruction,PettyOfficerClaud...
(Date:11/23/2009)... , Animal studies suggest that adding flaxseed oi...s in post-menopausal women and women with diabetes...ternational Journal of Food Safety, Nutrition and ...e National Research Center, in Cairo, Egypt, have ...evaluated how flaxseed oil in the diet might delay...
(Date:11/23/2009)... , Since 1996, crop plants genetically modified t...tain insects, yet safe for people, have been plant...e popularity of these Bt crops, named after the ba... ability to kill some major pests, allowing farmer...y reducing insecticide sprays. , However, since ...
(Date:11/23/2009)... Adding drug to chemo regimen may improve patient... Nov. 23 (HealthDay News) -- A new combination dru...advanced biliary-tract cancers, researchers say. ,...tal Cancer Center in Boston found that survival an...mab (Avastin), an angiogenesis inhibitor that has ...
(Date:11/23/2009)... HIV patients who have it take longer to get sick...hDay News) -- Scientists report that a genetic var...ease progression in HIV-infected patients. , ...ears longer to develop AIDS and die of complicatio...ors that vary across individuals that make a perso...
Breaking Medicine News(10 mins):Health News:Nothing Is Like Being There 2Health News:Flaxseed oil and osteoporosis 2Health News:Insect resistance to Bt crops can be predicted, monitored and managed 2Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2
...s that getting hospitals conscious about quality o...ts dying in that hospital. 26 percent fewer p...ttack when hospitals used quality-improvement // ...steps included a checklist that doctors, nurses an...
...boratories Thursday announced it had entered a co-...enmark-based Rheoscience A/S for the joint develop...the pact, Rheoscience will fund all costs associat... will pay Rheoscience a pre-determined amount towa...
... and team from the Institute of Tropical Medicine ...al AIDS, in which they have said that the HIV viru...iplication rate and is now more sensitive to anti-...ollected during 2002-03. The researchers compared ...
...on form of thalassaemia disease may not require bl...oglobin E ? thalassaemia—the commonest form of sev...managed without transfusion in many patients, sugg...es of donated blood—a scarce resource in many coun...
...ein has helped bald mice to get fur on the body, s... Catherine C. Thompson and colleagues at Johns...nd studied a gene known as Hairless, which encodes...rmal. But once hair is shed, it does not grow back...
...ss is considering whether to temporarily ban the E...man tests to determine whether a pesticide should ... decide whether to place a one year moratorium on ...es approved by the agency for marketing. The...
Other Medicine News:Health News:Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru 2Health News:US Senate Votes against Testing of Pesticide on Humans 2
(Date:11/23/2009)..., IRVINE,Calif.,Nov.23/PRNewswire/--AdvancedSte...ventionsolutionprovider,announcedtodaytheacquisiti...,aprivatelyhelddeveloperofinnovativedisinfectionpr...infections.Termsoftheacquisitionwerenotdisclosed. ...eadecontaminationtechnologythatprovidesdisinfectio...
(Date:11/20/2009)... , BOSTON, Nov. 20 The Uni... upheld an earlier District Court ruling yesterday...ge Wholesale Price (AWP) pharmaceutical litigation... (Logo: http://www.newscom.com/cgi-bin/prnh/20080...ment that awarded consumers who purchased the phar...
(Date:11/20/2009)... , LOUISVILLE, Ky., Nov. 20 /PRNewswire/ -...tigators (NADDI) today announced a new initiative ...rsor Log Exchange (NPLEx) is a multi-state electro...tions on over-the-counter (OTC) medicines containi...le. The technology for NPLEx is based on a system...
Breaking Medicine Technology:ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 1KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 4Scientists remove amyloid plaques from brains of live animals with Alzheimers disease 10367 1Scientists remove amyloid plaques from brains of live animals with Alzheimers disease 10367 2SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 1SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 2SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 3SAMHSA Honors The Soloist Greys Anatomy United States Of Tara and Mental Health Consumer Leaders at The Star Studded 2009 Voice Awards 59512 4
...esented on Valopicitabine Combined,with an Investi...il 12, 2007 /PRNewswire-FirstCall/ --,Idenix Pharm...phase,IIb studies of the novel combination of valo...a (Pegasys(R)) in both treatment-naive,and treatme...e-1,strain of the hepatitis C virus (HCV). These d...
...osts of eradicating,poliomyelitis from the remaini...m, are much lower than the long term costs of tryi...a recently developed,monovalent vaccine is almost ...litis than an existing trivalent vaccine. These ar...d in an upcoming,issue of The Lancet. , Both Artic...
Other Medicine Technology:Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 2Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 3Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 4Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 5Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 6Idenix Reports Results from Two Phase IIb Studies of the,Combination of Valopicitabine and Pegylated Interferon in Hepatitis,C Genotype-1 Patients at the 42nd Annual Meeting of the European,Association for the Study of the Liver 7Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
FF 450plus IR
... for fast and easy operation with advanced lens me...utomatically held when the lens is properly aligne...The sophisticated alignment system guides you to c...designed with a small footprint, occupying little ...
CR6-45NM Non-Mydriatic Retinal Camera
TRC-50FXC
Medicine Products: